Real and potential benefits of third-generation calcium antagonists
The paper considers the specific features of the pharmacokinetics of third-generation dihydropyridines (membrane-controlled pharmacokinetics). Comparative trials have shown their longer action and high efficacy, which are highly competitive with those of major groups of antihypertensive drugs. Lerca...
Main Author: | |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IP Morozov P.V.
2013-03-01
|
Series: | Системные гипертензии |
Subjects: | |
Online Access: | https://syst-hypertension.ru/2075-082X/article/view/28949 |